- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/06 - Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
Patent holdings for IPC class A61P 1/06
Total number of patents in this class: 236
10-year publication summary
|
19
|
5
|
22
|
15
|
15
|
29
|
22
|
25
|
13
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Thetis Pharmaceuticals LLC | 23 |
7 |
| Ltd "valenta-intellekt" | 153 |
5 |
| Société des Produits Nestlé S.A. | 9190 |
4 |
| Janssen Pharmaceutica N.V. | 3432 |
4 |
| BioGaia AB | 197 |
4 |
| enGene, Inc. | 37 |
4 |
| Heptares Therapeutics Limited | 114 |
4 |
| Cinclus Pharma Holding AB | 17 |
4 |
| Allergan, Inc. | 2359 |
3 |
| BGI Shenzhen Co., Limited | 277 |
3 |
| Universita degli Studi di Padova | 265 |
3 |
| Landos Biopharma, Inc. | 37 |
3 |
| Fondazione Citta' della Speranza-onlus | 7 |
3 |
| Chain Biotechnology Limited | 9 |
3 |
| Nxera Pharma UK Limited | 131 |
3 |
| Bristol-myers Squibb Company | 4897 |
2 |
| Nestec S.A. | 2680 |
2 |
| Boehringer Ingelheim International GmbH | 4701 |
2 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 594 |
2 |
| The Johns Hopkins University | 5637 |
2 |
| Other owners | 169 |